
Academic Journal
Q4Tijdschrift voor Urologie
About Tijdschrift voor Urologie
About Tijdschrift voor Urologie
Tijdschrift voor Urologie is the peer-reviewed Dutch-language journal of urology published for the Nederlandse Vereniging voor Urologie (NVU), the Dutch urological society. Its print ISSN is 2211-3037 and its electronic ISSN is 2211-4718, as stated on its official Springer Nature journal pages. Springer describes it, in Dutch, as the only peer-reviewed Dutch-language journal in the field, appearing eight times a year and containing, alongside scientific articles, case reports and the abstracts of the NVU's spring and autumn meetings. That description defines the journal precisely: it is a national society journal, written in Dutch for urologists practising in the Netherlands and Flanders, combining original clinical science with the case material and society proceedings that a practising specialist actually reads. This profile sets out its verified bibliographic record, its contents and rhythm, its indexing, its publisher and society ownership, and its citation record as reported by OpenAlex, so that authors, librarians and readers can judge it on facts rather than on a short directory entry.
Two corrections to common directory data should be noted at the start, because they affect how the journal is catalogued. First, the journal is Dutch, not American: the stored Journals World record for this post describes the publisher as a numeric code with the country given as the United States, which is incorrect. OpenAlex records the host organisation as Bohn Stafleu van Loghum — the Dutch medical imprint of Springer Nature — with country code NL, and Springer's own page carries the copyright line of the Nederlandse Vereniging voor Urologie. Second, the journal's language is a feature, not a limitation to be apologised for: it exists to serve Dutch-language clinical practice, guideline discussion and society business, and its contents are chosen for that readership.
Journal at a Glance
- Title: Tijdschrift voor Urologie
- Print ISSN: 2211-3037
- Electronic ISSN: 2211-4718
- Publisher: Bohn Stafleu van Loghum (Springer Nature), Netherlands
- Society: Nederlandse Vereniging voor Urologie (NVU)
- Country: Netherlands
- Language: Dutch
- Frequency: 8 issues per year, according to the official Springer journal page
- Contents: scientific articles, case reports, and abstracts of the NVU spring and autumn meetings
- Springer journal page: link.springer.com/journal/13629
- Submission to first decision (median): 25 days, as reported on the official Springer page
- Downloads: 149.7k in 2025, as reported on the official Springer page
Scope and Contents
As the journal of a national urological society, Tijdschrift voor Urologie covers the full breadth of clinical urology as it is practised in the Netherlands: urological oncology, endourology and stone disease, benign prostatic disease and lower urinary tract symptoms, functional urology and incontinence, andrology and sexual medicine, paediatric urology, reconstructive urology, infection, imaging and diagnostics, and the surgical and medical treatments that cut across those areas. The official description emphasises three content types, and each serves a distinct purpose. Scientific articles carry original clinical research, reviews and guideline-related work for the Dutch practice setting. Case reports present instructive individual cases — the unusual presentation, the unexpected complication, the diagnostic trap — in a form a clinician can read quickly and remember. The meeting abstracts preserve the NVU's spring and autumn meeting programmes in the published record, which makes the journal a partial archive of what Dutch urology was working on in a given year.
That mixture is the signature of a society journal and should guide both readers and authors. A reader looking for the Dutch position on a contested clinical question, a summary aimed at practising specialists rather than at researchers, or the abstract of a talk given at an NVU meeting will find material here that international English-language urology journals do not carry. An author with a study of Dutch practice — an audit, a guideline-implementation report, a national survey, a case series from a Dutch centre — has here a venue whose readership is exactly the community that can act on the findings. Conversely, a large international trial report or a basic-science study with no particular connection to Dutch practice would normally seek an international journal first, not because this journal's standards are lower, but because its audience is defined by language and by national practice.
Publisher, Society and Editorial Identity
The journal is published by Bohn Stafleu van Loghum, the Dutch health and medicine imprint within Springer Nature, on behalf of the Nederlandse Vereniging voor Urologie, whose copyright line appears on the official journal page. Society ownership of this kind has practical consequences. The journal's continuity does not depend on a commercial publisher's portfolio decisions alone; its meeting abstracts and society content give it a guaranteed core of relevant material; and its editorial priorities can reflect the professional community's needs — training, guidelines, quality of care — alongside research novelty. The journal is distributed and read through Springer's platform, which provides the journal's official pages, article pages, metrics display and indexing feeds.
OpenAlex's source record for the journal (S4210188076, resolved through the ISSN endpoint for 2211-3037) independently confirms the bibliographic core of this profile: ISSNs 2211-3037 and 2211-4718, host organisation Bohn Stafleu van Loghum, homepage on the Springer journal site, and a publication record in that corpus running from 2011. The stored Journals World record likewise gives a coverage span beginning in 2011. That span is best understood as the coverage window of the current series in the databases consulted, and readers tracing older Dutch urological literature should consult the NVU and the publisher for the journal's earlier history rather than assuming the title began in 2011.
Indexing and Discoverability
Springer's official page lists the services in which the journal is abstracted and indexed. The list consulted for this profile comprises: Baidu, CLOCKSS, CNKI, CNPIEC, the Chinese Academy of Medical Science (CAMS), Dimensions, EBSCO, Google Scholar, the Japanese Science and Technology Agency (JST), Naver, OCLC WorldCat Discovery Service, Ovid Discovery, Portico, ProQuest, SCImago, Scopus, Semantic Scholar, TD Net Discovery Service, Wanfang, and eLibrary.ru. Two entries deserve emphasis. Scopus indexing means the journal's articles enter the citation database most commonly used for bibliometric work in medicine, and SCImago listing means a SCImago journal record exists from which quartile and SJR-type indicators are derived; this profile does not quote a specific SJR value or quartile, because none was taken from a SCImago page directly consulted for it, and such figures change annually. The presence of both preservation services (CLOCKSS, Portico) also matters for librarians: the journal's archive is covered by recognised long-term preservation arrangements.
A Directory of Open Access Journals (DOAJ) listing could not be verified for this profile: the DOAJ search-API check performed for the stored ISSN returned no result, and a single interim search result is not treated here as proof of listing status in either direction. The journal is a society journal distributed through a commercial publisher's platform, and its access model for individual articles should be checked on the article and journal pages on SpringerLink at the time of reading or submitting. No article-processing charge is stated in this profile, because none could be verified from a source consulted for it; authors should confirm any charge, and any society-member arrangements, with the editorial office or the Springer journal pages before submitting.
Metrics and Citation Record
The journal's own platform reports two current service metrics on its official Springer page: a median time from submission to first decision of 25 days, and 149.7 thousand downloads in 2025. The first figure is a useful, concrete guide for authors weighing where to send a clinically time-sensitive manuscript, although it is a median reported by the publisher and individual manuscripts will vary. The second shows that, within its language community, the journal is actively read and downloaded, which for a national society journal is at least as meaningful as a citation average.
OpenAlex, in the source record consulted for this profile, reports 912 works and 291 citations for the journal, an h-index of 7, an i10-index of 4, and a two-year mean citedness of approximately 0.10, with a first publication year of 2011 and a last publication year of 2025 in that corpus. The stored Journals World record gives an h-index of 10. This profile reports both values with their sources rather than merging them: OpenAlex counts citations within its own open corpus, while other databases count within theirs, and a Dutch-language clinical journal will inevitably show modest international citation totals because much of its influence runs through practice, guidelines and teaching in its own country rather than through citations in English-language papers. That is a property of the journal's mission, and it is why the download and decision-time figures from its own platform are reported alongside the citation data here. No Clarivate Journal Impact Factor is stated, because none could be verified from a source consulted for this profile.
How to Publish in Tijdschrift voor Urologie
Begin on the official Springer journal pages, which carry the current submission route, author instructions and editorial contacts for the journal; those pages govern in case of any difference from this profile. Write in Dutch and write for the practising Dutch urologist: a clear clinical question, a concise account of methods and results, and an explicit statement of what the findings mean for practice in the Netherlands will serve a manuscript better than a long international-style literature survey. Case reports should make the teaching point unmistakable — what was unexpected, what was learned, and what a colleague should do differently — and should follow the journal's current requirements on patient consent and anonymisation, which authors must confirm in the author instructions before submitting. Meeting abstracts follow the NVU meeting process rather than the ordinary article route, and the deadlines and formats for those are set by the society and the journal for each meeting.
Before submitting, authors should also confirm the practical terms on the official pages: the current article types accepted, any length and figure limits, the referencing style, the access model that will apply to the published article, and whether any charge applies. None of those details is asserted in this profile where it could not be verified. What can be said from the verified record is that the journal offers a defined national audience, a publisher-reported median first decision of 25 days, Scopus indexing, and the standing of the Dutch urological society's own journal — a combination that suits Dutch clinical research, audits, guideline work and instructive case material particularly well.
Who Should Consider This Journal, and Who Should Not
Consider Tijdschrift voor Urologie if you practise or research in the Netherlands or Flanders, if your material concerns Dutch urological practice, training, guidelines or service organisation, if you have an instructive case for Dutch colleagues, or if you presented at an NVU meeting and your abstract belongs in the journal's proceedings record. Consider it, too, if a fast and clearly reported first decision matters and your work is written, or can be written well, in Dutch. Look elsewhere if your manuscript is in English and aimed at an international research audience, if it reports a multinational trial or laboratory science with no Dutch practice dimension, or if your evaluation requires a Journal Impact Factor — none could be verified for this journal in the sources consulted. Language, audience and society fit are the right tests for this journal, ahead of any ranking table.
Frequently Asked Questions
What are the journal's ISSNs? Print ISSN 2211-3037 and electronic ISSN 2211-4718, as stated on the official Springer journal page and confirmed in the OpenAlex source record.
Who owns and publishes the journal? It is the journal of the Nederlandse Vereniging voor Urologie, published by Bohn Stafleu van Loghum (Springer Nature) in the Netherlands. Directory entries giving a United States publisher for this title are incorrect.
How often does it appear and what does it contain? Eight times a year, according to Springer, with scientific articles, case reports and the abstracts of the NVU spring and autumn meetings.
Is it indexed in Scopus? Yes — Scopus and SCImago appear in the abstracting and indexing list on the journal's official Springer page, along with Dimensions, EBSCO, Google Scholar, ProQuest and others.
How fast is a first decision? Springer reports a median of 25 days from submission to first decision on the journal's official page; individual manuscripts will vary.
What are its citation metrics? OpenAlex reports 912 works, 291 citations and an h-index of 7 in the record consulted; the stored Journals World record gives an h-index of 10. Quote any figure with its source and the date checked.
Reading Tijdschrift voor Urologie as a Record of Dutch Practice
One under-appreciated use of a society journal is as a longitudinal record of a specialty inside one health system. Because Tijdschrift voor Urologie publishes the abstracts of the NVU's spring and autumn meetings alongside its articles and case reports, a run of its volumes shows what Dutch urology was prioritising in successive years: which cancers and which operations dominated the programmes, how quickly new techniques — minimally invasive surgery, new imaging, new systemic therapies — entered ordinary Dutch practice, and which questions of training, capacity and organisation of care the profession was debating with itself. A researcher studying the diffusion of a technique, a historian of Dutch medicine, or a clinician preparing a guideline update can use the journal in that documentary way, and for that purpose the completeness of the proceedings record matters more than citation counts. The same completeness makes the journal valuable to Dutch trainees: the case reports and meeting material show the range of problems a Dutch urologist is expected to recognise, in the language in which Dutch multidisciplinary teams actually discuss them.
That documentary role also explains the journal's download figures. Springer's reported 149.7 thousand downloads in 2025 is a large readership for a journal in a language spoken by a population of the size of the Netherlands and Flanders, and it indicates that the journal is used as a working clinical resource, not merely archived. For an author, the practical consequence is that well-judged, practice-facing material — a clear review of a common problem, an honest audit with usable lessons, a case that changes how a reader will handle the next similar patient — is likely to be genuinely read here. For a librarian, the consequence is that the title earns its place in a Dutch or Belgian medical collection on usage as well as on indexing. And for an evaluator, the consequence is a reminder to assess a national society journal against its own stated mission: serving the Dutch-language urological community with peer-reviewed science, case material and the society's proceedings, eight times a year. On the verified evidence in this profile, that is the mission the journal performs.
A Note on Language and Audience
Authors sometimes ask whether a Dutch-language society journal can have any relevance outside its own language area, and the verified record gives a practical answer. Its indexing in Scopus, Dimensions, Semantic Scholar and Google Scholar means its articles are discoverable in international searches, with their Dutch titles and abstracts surfacing wherever a searcher's question matches them; a systematic reviewer working on a urological topic cannot responsibly ignore the Dutch literature in a country with a strong clinical research tradition, and this journal is one of the places that literature appears. At the same time, the journal makes no claim to be an international English-language title, and its society, publisher, frequency, contents and metrics are all oriented to the Dutch urological community it serves. Holding both facts together — internationally discoverable, nationally addressed — is the accurate description, and it is the description on which the submission advice in this profile rests: write for the Dutch reader first, in Dutch, on a question Dutch practice needs answered, and let international discoverability follow from the indexing the journal already has.
Verification Notes for Readers
This journal's record is a useful case study in why publisher and country fields in large directories must be checked against the journal itself. A record that placed a Dutch-language society journal in the United States under a numeric publisher code was not a harmless formatting quirk: a librarian relying on it would misfile the title, an author relying on it would misunderstand the journal's audience entirely, and an evaluator relying on it would look for the journal in the wrong country's research landscape. The correction in this profile rests on two independent, directly consulted sources — the journal's own Springer pages, carrying the Nederlandse Vereniging voor Urologie's copyright line and the journal's Dutch description, frequency and indexing, and the OpenAlex record naming Bohn Stafleu van Loghum in the Netherlands — which agree with each other and with the journal's language and society. The same two-source discipline produced the rest of the profile: the frequency and contents from the publisher, the citation figures from a named corpus with the stored record's differing h-index reported beside them, and the service metrics from the journal's own platform. Where the two-source test could not be met — a DOAJ listing, a Journal Impact Factor, an article-processing charge — this profile says so, and a reader who needs those facts should obtain them from the journal's official pages, where any change will appear first.
Sources and Verification
This profile is based on the journal's official Springer Nature pages (description, frequency, contents, ISSNs, society copyright line, indexing list, submission-to-first-decision median and 2025 downloads), the OpenAlex source record resolved via the ISSN endpoint for 2211-3037 (source S4210188076: ISSNs, host organisation, works, citations, h-index, i10-index, two-year mean citedness, publication years, homepage), and the stored Journals World record for this post (title, slug, stored ISSNs and coverage window), whose publisher and country fields were found to be incorrect and are corrected above on the basis of the official and OpenAlex records. A DOAJ listing and a Clarivate Journal Impact Factor could not be verified from sources consulted, and no article-processing charge is stated for the same reason.
Source-backed journal facts
Topics in published research
Urological Disorders and Treatments; Prostate Cancer Diagnosis and Treatment; Prostate Cancer Treatment and Research; Bladder and Urothelial Cancer Treatments; Clinical practice guidelines implementation; Urinary Bladder and Prostate Research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-09-19. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Prostaatkankerspecifieke sterfte bij mannen met en zonder comorbiditeit: langetermijnresultaten van de ERSPC-Rotterdam
Sanne F. Westerhout, Sebastiaan Remmers, Chris H. Bangma, Geert J. L. H. van Leenders et al.
2026-10-23 · DOI: 10.1007/s13629-026-00517-4Wat is de prognostische waarde van cribriforme groei voor de keuze tot active surveillance bij prostaatkanker?
André N. Vis, Bernard H. E. Jansen-Stensland
2026-10-13 · DOI: 10.1007/s13629-026-00516-5Case report. Pulmonale lijmembolieën en interstitiële pneumonitis na endovasculaire embolisatie van een varicocele met cyanoacrylaat
Seyed Qaderi, Fatih Güçlü, Max Rietkerk, Rob Janssen et al.
2026-10-09 · DOI: 10.1007/s13629-026-00513-8Diagnostic value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in staging histological subtypes of invasive bladder cancer
Renee A. G. Lijnen, Joanneke B. Ringia, Francesco Claps, Wouter V. Vogel et al.
2026-10-07 · DOI: 10.1007/s13629-026-00514-7Bijzondere zorg
Henk G. van der Poel
2026-10-06 · DOI: 10.1007/s13629-026-00515-6Abstracts Najaarsvergadering NVU, 30 oktober 2026
Peter F.A. Mulders
2026-10 · DOI: 10.1007/s13629-026-0903-6Goede registratie leidt tot toenemend urologisch onderzoek
Peter F.A. Mulders
2026-10 · DOI: 10.1007/s13629-026-0902-7Variatie in de behandeling van stress-urine-incontinentie: een analyse op basis van vragenlijstresultaten
Noortje Jongeling, Philip Oldenburg, Janneke van Uhm, René Schellart et al.
2026-09-04 · DOI: 10.1007/s13629-026-00509-4De uroloog mét AI vervangt de uroloog zonder AI
Willem Brinkman, Michel Wyndaele, Rianne Lammers
2026-09 · DOI: 10.1007/s13629-026-00510-xNatural language processing in de urologische praktijk: van data naar besluitvorming
Saskia Weltings, David J. Vinkers
2026-09 · DOI: 10.1007/s13629-026-00512-9AI-voorspelmodellen: ongeplande heropnamen en flebitis
Ernst P. van Haarst, Koen Welvaars
2026-09 · DOI: 10.1007/s13629-026-00511-wAI-agents in de onderzoekscyclus: een praktische handleiding voor het versnellen van scoping reviews
Bart Witte, Liselot Ribbert, Felix Frijns, Emma van Toorenburg et al.
2026-09 · DOI: 10.1007/s13629-026-00507-6Klinische kenmerken en chirurgische behandeling van urogenitale endometriose: een retrospectief cohortonderzoek
Hanzhe Dong, Eefje Oude Lohuis, Johanna M. A de Bruin, Bob Theodoor Merks et al.
2026-08-27 · DOI: 10.1007/s13629-026-00504-9Tussen potentie en praktijk: AI als motor voor zorgtransformatie bij prostaatkanker
Robert N. Spaans, Nadieh Khalili, Geert Litjens, Jean-Paul van Basten et al.
2026-09 · DOI: 10.1007/s13629-026-00505-8AI in de robotchirurgie
Willem M. Brinkman, Tim J. M. Jaspers
2026-09 · DOI: 10.1007/s13629-026-00506-7Verantwoord generatieve kunstmatige intelligentie-gebruik van de student begint bij de docent
Kai Yu Ma, Margreet J. Smit
2026-09 · DOI: 10.1007/s13629-026-00508-5De waarde van oude en nieuwe technieken in de urologie
Peter F. A. Mulders
2026-08 · DOI: 10.1007/s13629-026-00503-wTweede tranche
H. G. van der Poel
2026-07 · DOI: 10.1007/s13629-026-00499-3Het effect van N-hexylcyanoacrylaat (NHCA) versus partikels voor prostaatembolisatie bij patiënten met een verblijfskatheter als gevolg van een urineretentie door BPH
Annemarth P. Lambregts, Yvette D. Dubbelman, Alexander Venmans, Bart P. Wijsman et al.
2026-05-19 · DOI: 10.1007/s13629-026-00501-yMate van overeenkomst in het scoren van mictieklachten bij de patiënt tussen de patiënt en zijn partner
Noa A. Vonk, Florine W. M. Schlatmann, Michael R. van Balken
2026-05-19 · DOI: 10.1007/s13629-026-00502-xReviews
Community Reviews
Version History
October 19, 2026 at 10:00 am
October 2, 2026